These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 11384563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA, Leahy C, Krenzer KL.
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis. Emadine Study Group.
    Secchi A, Leonardi A, Discepola M, Deschenes J, Abelson MB.
    Acta Ophthalmol Scand Suppl; 2000 Dec; (230):48-51. PubMed ID: 11057351
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emedastine and allergic conjunctivitis: new preparation. Poor assessment.
    Prescrire Int; 2001 Apr; 10(52):39-40. PubMed ID: 11718155
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countries.
    Pinto CG, Lafuma A, Fagnani F, Nuijten MJ, Berdeaux G.
    Pharmacoeconomics; 2001 Apr; 19(3):255-65. PubMed ID: 11303414
    [Abstract] [Full Text] [Related]

  • 9. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C, Metzenauer P, Petzold U, Ellers-Lenz B.
    Curr Med Res Opin; 2000 Apr; 16(3):153-63. PubMed ID: 11191004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P, Allewaert R, Joyaux JC, Piozzi E, Koliopoulos J, Bloch-Michel E, Lodoxamide Study Group.
    Eur J Ophthalmol; 2001 Apr; 11(2):120-5. PubMed ID: 11456011
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
    Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
    [Abstract] [Full Text] [Related]

  • 15. Tolerability of levocabastine eye drops.
    Janssens M, Blockhuys S.
    Doc Ophthalmol; 1993 Sep; 84(2):111-8. PubMed ID: 7905376
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
    Richard C, Trinquand C, Bloch-Michel E.
    Eur J Ophthalmol; 1998 Sep; 8(4):207-16. PubMed ID: 9891891
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The early efficacy of topical levocabastine in patients with allergic conjunctivitis.
    Fujishima H, Fukagawa K, Takano Y, Okamoto S, Nakagawa Y, Uchio E, Yokoi N, Fukushima A, Takamura E.
    Allergol Int; 2006 Sep; 55(3):301-3. PubMed ID: 17075271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.